Abiopharma

🔍 Nonko Eugene (Director)

Company: MediaAlpha, Inc. (MAX)

Report Date: 2026-07-27

Detailed Transactions and Holdings:

• Sold 3,282 shares of Class A Common Stock at $13.2761 per share (Direct)
  Date: 2026-07-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 872,436.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 6,622 shares of Class A Common Stock at $13.8592 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 865,814.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 4,952 shares of Class A Common Stock at $14.0491 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 860,862.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 8,205 shares of Class A Common Stock at $13.2764 per share (Direct)
  Date: 2026-07-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,052,907.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 10,843 shares of Class A Common Stock at $13.7762 per share (Direct)
  Date: 2026-07-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,042,064.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 9,524 shares of Class A Common Stock at $14.0466 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,032,540.00 | transaction_form_type: 4 | Footnotes: F1, F6

Footnotes:

• F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person primarily to cover taxes resulting from the vesting of RSUs.
• F2: Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $13.225 to $13.345 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F3: Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $13.62 to $14.01 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F4: Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $13.89 to $14.225 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F5: Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $13.505 to $14.01 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F6: Reflects the weighted-average sale price for shares sold in multiple transactions at prices ranging from $13.89 to $14.255 per share. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.